<DOC>
	<DOC>NCT00931944</DOC>
	<brief_summary>This is an open-label, multi-center study designed to extend the evaluation of the safety, tolerability, and clinical effects of oral administration of KNS-760704 in patients with ALS.</brief_summary>
	<brief_title>Open-Label, Safety and Tolerability Extension Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS) (CL211)</brief_title>
	<detailed_description>Patients who complete the Part 2 Week 28 visit in study KNS-760704-CL201 and patients with ALS who are actively receiving RTPB [(6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazolediamine dihydro-chloride monohydrate] under Research IND #60,948 may be eligible to participate in this study. Eligible patients will receive 1 tablet of KNS-760704 150 mg every 12 hours (Q12H) (300 mg total daily dose) for up to 180 weeks.</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<mesh_term>Pramipexole</mesh_term>
	<criteria>1. Patient has provided signed informed consent for this trial before the commencement of any studyrelated procedure 2. Patient is actively participating in Knopp Protocol KNS760704CL201 and has completed the Part 2 Week 28 visit in that study or patient is actively receiving RTPB under Research IND #60,948 1. Patient did not participate in Knopp Protocol KNS760704CL201 or patient did not receive RTPB under Research IND #60,948. 2. Patient discontinued from KNS760704CL201 for any reason other than enrollment into this study (applies to patients enrolled in KNS760704CL201 only) 3. Patient was not taking RTPB under Research IND #60,948 prior to April 30, 2009 (applies to patients enrolled under Research IND #60,948 only)</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>ALS</keyword>
	<keyword>Amyotrophic Lateral Sclerosis</keyword>
	<keyword>Lou Gehrig</keyword>
	<keyword>Lou Gehrig's</keyword>
	<keyword>Lou Gehrig's disease</keyword>
	<keyword>Motor Neuron Disease</keyword>
	<keyword>Nervous System Diseases</keyword>
	<keyword>KNS-760704</keyword>
	<keyword>RTPB</keyword>
</DOC>